Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study to Assess the Screening Value of N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) for the Identification of Patients That Benefit From Additional Cardiac Testing Prior to Vascular Surgery

NCT00519961 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT00519961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00519961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study to Assess the Screening Value of N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) for the Identification of Patients That Benefit From Additional Cardiac Testing Prior to Vascular Surgery
Lead sponsor
Hoffmann-La Roche
Phase
Not applicable
Overall status
Unknown status
Start date
February 28, 2007
Completion date
September 30, 2010
Enrollment
1,800 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral vascular disease